Europos Sąjunga - anglų - EMA (European Medicines Agency)

roche registration ltd. - ibandronic acid - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of osteoporosis in post-menopausal women at increased risk of fracture.a reduction in the risk of vertebral fractures has been demonstrated. efficacy on femoral-neck fractures has not been established.

Airija - anglų - HPRA (Health Products Regulatory Authority)

bayer limited - calcium carbonate; magnesium carbonate - chewable tablet - 680 mg/80 milligram(s) - magnesium carbonate; calcium carbonate; antacids, other combinations

Airija - anglų - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - zoledronic acid monohydrate - concentrate for solution for infusion - 4 mg/5ml - bisphosphonates; zoledronic acid

Malta - anglų - Medicines Authority

forest laboratories uk limited whiddon valley, barnstaple north devon, ex32 8ns, united kingdom - calcium carbonate, magnesium carbonate, light, sodium hydrogen - chewable tablet - calcium carbonate 522 mg magnesium carbonate, light 68 mg sodium hydrogen carbonate 64 mg - drugs for acid related disorders

Australija - anglų - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - calcium carbonate,colecalciferol,risedronate sodium -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - calcium carbonate,colecalciferol,risedronate sodium -

Airija - anglų - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - zoledronic acid - concentrate for solution for infusion - 4/5 milligram(s)/millilitre - bisphosphonates; zoledronic acid

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

heritage pharmaceuticals inc. - zoledronic acid (unii: 6xc1pad3kf) (zoledronic acid anhydrous - unii:70hz18ph24) - zoledronic acid injection is indicated for treatment of paget's disease of bone in men and women. treatment is indicated in patients with paget's disease of bone with elevations in serum alkaline phosphatase of two times or higher than the upper limit of the age-specific normal reference range, or those who are symptomatic, or those at risk for complications from their disease [see clinical studies (14.5) ]. zoledronic acid injection is contraindicated in patients with the following conditions: - hypocalcemia [see warnings and precautions (5.2) ] - creatinine clearance less than 35 ml/min and in those with evidence of acute renal impairment due to an increased risk of renal failure [see warnings and precautions (5.3) ]. - known hypersensitivity to zoledronic acid or any components of zoledronic acid injection. hypersensitivity reactions including urticaria, angioedema, and anaphylactic reaction/shock have been reported [see adverse reactions (6.2) ]. pregnancy category d [see warnings and precautions (5.6)

Malta - anglų - Medicines Authority

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - calcium carbonate, magnesium carbonate, heavy - chewable tablet - calcium carbonate 680 mg magnesium carbonate, heavy 80 mg - drugs for acid related disorders

Australija - anglų - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - alendronate sodium, quantity: 91.35 mg (equivalent: alendronic acid, qty 70 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; macrogol 8000; carrageenan; magnesium stearate - treatment of osteoporosis, including glucocorticoid induced osteoporosis. osteoporosis must be confirmed by the finding of low bone mass of at least two standard deviations below the gender specific mean for young adults, or by the presence of osteoporotic fracture.